amlodipine/indapamide/telmisartan
Jump to navigation
Jump to search
Indications
- initial treatment of hypertension
Dosage
- telmisartan: 10 mg, indapamide: 0.625 mg, amlodipine: 1.25 mg
- telmisartan: 20 mg, indapamide: 1.25 mg, amlodipine: 2.5 mg
Mechanism of action
More general terms
Components
References
- ↑ Rodgers A, Salam A, Schutte AE, et al. Efficacy and Safety of a Novel Low-Dose Triple Single-Pill Combination Compared With Placebo for Initial Treatment of Hypertension. J Am Coll Cardiol. 2024 Aug 30:S0735-1097(24)08227-5. PMID: https://www.ncbi.nlm.nih.gov/pubmed/39217570
- ↑ Ojji DB, Salam A, Sani MU Low-Dose Triple-Pill vs Standard-Care Protocols for Hypertension Treatment in Nigeria: A Randomized Clinical Trial. JAMA. 2024 Oct 1;332(13):1070-1079. PMID: https://www.ncbi.nlm.nih.gov/pubmed/39215620 PMCID: PMC11366076 (available on 2025-03-03) Clinical Trial.
- ↑ Rodgers A, Salam A, Schutte AE et al Efficacy and safety of a novel low-dose triple single-pill combination of telmisartan, amlodipine and indapamide, compared with dual combinations for treatment of hypertension: a randomised, double-blind, active-controlled, international clinical trial. Lancet. 2024 Oct 19;404(10462):1536-1546. PMID: https://www.ncbi.nlm.nih.gov/pubmed/39426836 Clinical Trial.